Your Top 50 most-cited badge

A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.

The article

First-Line Treatment With Atezolizumab Plus Bevacizumab and Chemotherapy for US Patients With Metastatic, Persistent, or Recurrent Cervical Cancer: A Cost-Effectiveness Analysis

Jianying Lei, Jiahao Zhang, Caicong You, Maobai Liu, Na Li

Rank
42 of 645
Percentile
top 6.6%
Where
Value in Health, 2024
Citations
13

From the 2024 list, OpenAlex counts as of 2026-10-29.

Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.